Asia Pacific Pharmaceuticals: Announcement on the first share repurchase and completion of the repurchase implementation and share changes
Securities code: 002370 Securities abbreviation: Asia Pacific Pharmaceutical Announcement number: 2026-068
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Announcement on the first repurchase of shares and the completion of the repurchase and changes in shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete.
It is complete and there are no false records, misleading statements or major omissions.
The 16th meeting of the eighth board of directors of Zhejiang Asia Pacific Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held on July 29, 2026 reviewed and approved the "Proposal on the Share Repurchase Plan", agreeing that the company will use its own funds and self-raised funds to repurchase some of the company's shares in a centralized bidding transaction for the implementation of equity incentives or employee stock ownership plans. The total amount of funds for this repurchase is not Less than RMB 10 million (inclusive) and no more than RMB 20 million (inclusive), the repurchase price shall not exceed RMB 7.00 per share (inclusive), and the repurchase period shall not exceed 12 months from the date when the board of directors considers and approves the repurchase plan. The specific number and proportion of repurchased shares shall be subject to the actual repurchase quantity and proportion when the repurchase period expires or the repurchase of shares is completed. For details, please refer to the "Announcement on the Plan to Repurchase the Company's Shares", "The Announcement on Obtaining a Special Loan Commitment Letter for Stock Repurchases from Financial Institutions" and "Report on Repurchasing Shares" published by the company on the designated information disclosure media "Securities Times" and cninfo.com (www.cninfo.com.cn) on July 30, 2026 and August 5, 2026.
On August 11, 2026, the company implemented the share repurchase for the first time. This share repurchase matter has been completed. In accordance with the "Share Repurchase Rules of Listed Companies", "Shenzhen Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 9 - Share Repurchase" and other relevant regulations, the relevant matters are now announced as follows:
1. Implementation of repurchase of company shares
On August 11, 2026, the company repurchased the company's shares for the first time through a centralized bidding transaction through a special securities account for share repurchase. This time, 3,344,500 shares were repurchased, accounting for 0.45% of the company's total share capital. The highest transaction price was 6.03 yuan/share, the lowest transaction price was 5.91 yuan/share, and the total transaction amount was 19,998,005.00 yuan (excluding transaction fees).
The company's share repurchase has been completed. This repurchase complies with the requirements of relevant laws and regulations and is in line with the company's established share repurchase plan.
2. Explanation that there is no difference between the implementation of share repurchase and the share repurchase plan
The total amount of funds used by the company to repurchase shares, the repurchase price, the number of shares repurchased, the proportion and the implementation period of the repurchase are all in line with the share repurchase plan reviewed and approved by the company's board of directors. The company's repurchase amount has reached the lower limit of the repurchase amount in the share repurchase plan and has not exceeded the upper limit of the repurchase amount. The repurchase has been completed according to the disclosed share repurchase plan. There is no difference between the actual implementation and the disclosed share repurchase plan.
3. The impact of this repurchase on the company
This share repurchase will not have a significant impact on the company's operations, finance, research and development, debt performance capabilities and future development. It will not cause a change in the company's control, will not affect the company's listing status, and will not cause the company's equity distribution to fail to meet listing conditions.
This repurchase reflects firm confidence in the company's future development, helps improve the company's long-term incentive mechanism and benefit-sharing mechanism, fully mobilizes the enthusiasm of the company's core managers and business (technical) backbones, and promotes the company's healthy and sustainable development.
4. The purchase and sale of the company’s stocks by relevant entities during the implementation of the buyback
From the date when the company first disclosed the repurchase to the day before the disclosure of this announcement, the company's directors, senior managers, controlling shareholders, actual controllers and persons acting in concert did not buy or sell the company's stocks.
5. Estimated changes in shares
The company's repurchase plan has been completed, and the number of shares repurchased is 3,344,500 shares. If the repurchased shares are all used to implement equity incentives or employee stock ownership plans according to the intended purpose and are all locked up, calculated based on the current company's capital structure, the changes in the company's capital structure are expected to be as follows:
Before this repurchase After this repurchase
Share Class
Quantity (shares) Proportion (%) Quantity (shares) Proportion (%) Restricted tradable shares
45,000 0.01 3,389,500 0.45 Unlimited tradable shares
745,622,530 99.99 742,278,030 99.55Total share capital
745,667,530 100.00 745,667,530 100.00
Note: The above changes are preliminary calculation results, and the impact of other factors has not been taken into account. The specific changes in the share capital structure will be subject to the final registration status of the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd.
6. Compliance instructions for the implementation of share repurchase
The time of the company's share repurchase, the number of shares repurchased, the price of the repurchased shares and the entrustment period of the centralized bidding transaction are all in compliance with the "Share Repurchase Rules of Listed Companies", the Shenzhen Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 9 - Share Repurchase and the relevant provisions of the company's share repurchase plan, as follows:
(1) The company fails to repurchase the company’s shares during the following periods:
From the date when a major event that may have a significant impact on the trading price of the company's securities and its derivatives occurs or during the decision-making process to the date of disclosure in accordance with the law;
Other circumstances specified by the China Securities Regulatory Commission and the Shenzhen Stock Exchange.
(2) The company's repurchase of shares through centralized bidding transactions meets the following requirements:
The entrusted price shall not be the price that limits the trading increase of the company’s stock on that day;
Share repurchases shall not be entrusted during the opening call auction, closing call auction and trading days when the stock price has no limit on the price increase or decrease of the Shenzhen Stock Exchange;
Other requirements stipulated by the China Securities Regulatory Commission and Shenzhen Stock Exchange.
7. Follow-up arrangements for repurchased shares
The shares repurchased by the company will all be deposited in the company's special securities account for share repurchase. During the storage period, they will not have the right to vote at the shareholders' meeting, profit distribution, transfer of reserve funds to share capital, subscribe for new shares and convertible corporate bonds, and may not be pledged or lent. According to the company's repurchase plan, the shares repurchased this time will be used to implement equity incentives or employee stock ownership plans. If the company fails to implement the above purposes within three years after the completion of this share repurchase, the unused repurchased shares will be canceled according to relevant procedures in accordance with the law.
The company will promptly perform relevant decision-making procedures and information disclosure obligations based on the progress of the follow-up processing of the repurchased shares. Investors are kindly requested to invest rationally and pay attention to investment risks.
Announcement is hereby made.
Board of Directors of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
August 12, 2026